Department of Medicine, Section of Pharmacology, University of Perugia, P.le L. Severi 1, 06132, Perugia, Italy.
Department of Medicine, Section of Pharmacology, University of Perugia, P.le L. Severi 1, 06132, Perugia, Italy.
Biomed Pharmacother. 2017 Dec;96:1445-1452. doi: 10.1016/j.biopha.2017.12.001. Epub 2017 Dec 6.
Treatment of pain has always been a major goal in the clinic, as it is related to several pathological conditions of inflammatory origin and surgical procedures, which are associated with inflammatory mediators. Understanding the molecular mechanisms underlying the association between inflammatory mediators and pain perception, from peripheral to central sensitization, can provide the basis for the development of new pharmacological treatments. Despite safety concerns, till date, the use of non-steroidal anti-inflammatory drugs (NSAIDs) has been shown to be efficacious, safe, and well tolerated by patients. Thus, choosing the appropriate administration route, developing new formulations and lowering the efficacious dose represent, currently, effective means of treating inflammation and relieving the pain, without inducing significant side effects.
治疗疼痛一直是临床的主要目标,因为它与几种炎症来源的病理状况和与炎症介质相关的外科手术有关。了解炎症介质与疼痛感知之间的关联的分子机制,从外周到中枢敏化,可为开发新的药理学治疗方法提供基础。尽管存在安全性问题,但迄今为止,非甾体抗炎药(NSAIDs)的使用已被证明是有效、安全且患者耐受良好的。因此,选择适当的给药途径、开发新的制剂和降低有效剂量目前是治疗炎症和缓解疼痛而不引起明显副作用的有效手段。